Genomic & Biopharma News

COVID-19 pandemic may cause long-term effects and increase healthcare costs, says GlobalData
As many COVID-19 patients may experience long-term complications from the illness such as intensive care unit delirium, post-traumatic stress disorder, lung damage, heart damage and possible neurological issues, GlobalData expects the market for these treatments to increase due to the COVID-19 pandemic as recovered patients may need long-term care for these issues after being released from the intensive care unit and the hospital.
News Medical Life Sciences, 2020-06-04 06:51:00

GlobalData: Nearly 83.5% of orthopedic procedures estimated to be delayed in the U.S.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
News Medical Life Sciences, 2020-06-04 06:48:41

COVID-19: Clinical Pathways to Pandemic Relief
By Graeme Gardner, Ph.D.
ORB Company Blog, 2020-03-26 19:58:16

Exploring data transparency and quality measurements in Austrian healthcare system
A crisis like the corona pandemic demonstrates how important reliable information and transparent communication are, particularly when dealing with such a sensitive area as health.
News Medical Life Sciences, 2020-06-04 06:41:00

Space Biology: A Road to the Moon, Mars, and Beyond
It’s an exciting time in the field of space travel research. In 2019, SpaceX launched its Dragon spacecraft and Boeing launched its CST-100 Starliner. Both are designed to one day carry human passengers to their destination and home again. These launches represent a critical milestone towards NASA’s return to launching American astronauts to space from American soil using American commercial spacecraft.
ORB Company Blog, 2020-02-26 22:19:00

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2
Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19.
News Medical Life Sciences, 2020-06-04 06:37:16

Protein markers could help predict how ill a COVID-19 patient will become
Researchers at the Francis Crick Institute and Charité – Universitätsmedizin Berlin have identified 27 protein biomarkers that could be used to predict whether a patient with COVID-19 is likely to become severely ill with the disease.
News Medical Life Sciences, 2020-06-04 06:34:00

Study offers potential targets for treating people with Ehlers-Danlos syndrome
Researchers have discovered that a defective form of the protein aortic carboxypeptidase-like protein (ACLP) from patients with Ehlers-Danlos syndrome (EDS) is retained in cells and induces cellular stress.
News Medical Life Sciences, 2020-06-04 06:28:00

Study reveals opportunity to improve outcomes in young children with concussion
Head injuries that lead to concussions can happen at any age, and children impacted by concussions have different needs and recovery patterns.
News Medical Life Sciences, 2020-06-04 06:21:00

New TILDA study highlights the internet habits and behaviors of older adults
The COVID-19 pandemic has rapidly and dramatically changed how people interact, moving work and social communication online. Use of the internet to stay connected, socialise, shop and conduct business has expanded since the implementation of measures to curtail the spread of COVID-19.
News Medical Life Sciences, 2020-06-04 06:09:00

27 protein biomarkers predict COVID-19 severity in patients
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
News Medical Life Sciences, 2020-06-04 06:06:48